Hot Versus Hot: Jazz Pharmaceuticals plc (NASDAQ:JAZZ), lululemon athletica inc. (NASDAQ:LULU)

earnings estimates

Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) closed at $144.65 on the last trading session with an increase of 0%, whereas, it previously closed at $144.65. The company has a market capitalization of $8.51 Billion. The company traded shares of 0 on the trading day while its three month average volume stands at 599.33 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) produced diluted EPS of 5.93. The EPS estimate for next year as estimated by analysts is at 14.03 while EPS for next quarter is estimated at 2.96. Earnings per Share growth for this year is reported at -15.4, while the analysts estimated the EPS growth for next year at 14.03% and Earnings growth for next 5 years stands at 15.73% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 4.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is at 24.4 while the forward p/e is at 10.31. The P/S or Price to Sales ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 4.6 and Price to Book or P/B for the most recent quarter stands at 2.89. The Price to Free Cash Flow ratio or P/FCF is reported at 10.93. The quick ratio and the current ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are reported at 4.2 and 4.3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 9.8, 18.2 and 9.8 respectively

The trailing twelve month Revenue of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is reported at 1.85 Billion with income of 364.7 Million. The outstanding shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are 58.85 Million. The institutional Ownership of the shares of 96 stands at 0.80%, this figure is decreased -2.51 in the last six months. The insider ownership for the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is ticked at 2.5%, the figure is plummeted -0.59% in the last six months.

Some other important financial aspects to be discussed here for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is the Mean Target Price estimated by the analysts which stands at 186.22. The 52 week high of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is placed at 184.00 and 52 week low is standing at 130.15.

Performance wise the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) fell down -3.52% for the week, it also fell -11.3% for the monthly performance, while for the quarter it went up -15.56%. The shares decrease -17.48% for the half year and flew up for the Year-To-Date performance. The shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) grew 5.92% for the yearly performance.

lululemon athletica inc. (NASDAQ:LULU)

lululemon athletica inc. (NASDAQ:LULU) closed at $133.62 on the last trading session with an increase of 0%, whereas, it previously closed at $133.62. The company has a market capitalization of $17.28 Billion. The company traded shares of 0 on the trading day while its three month average volume stands at 1.89 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of lululemon athletica inc. (NASDAQ:LULU) produced diluted EPS of 3.02. The EPS estimate for next year as estimated by analysts is at 4.25 while EPS for next quarter is estimated at 0.69. Earnings per Share growth for this year is reported at 5.7, while the analysts estimated the EPS growth for next year at 4.25% and Earnings growth for next 5 years stands at 24.06% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 4.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of lululemon athletica inc. (NASDAQ:LULU) is at 44.26 while the forward p/e is at 31.45. The P/S or Price to Sales ratio of lululemon athletica inc. (NASDAQ:LULU) stands at 5.91 and Price to Book or P/B for the most recent quarter stands at 13.57. The Price to Free Cash Flow ratio or P/FCF is reported at 42.62. The quick ratio and the current ratio of lululemon athletica inc. (NASDAQ:LULU) are reported at 2 and 2.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for lululemon athletica inc. (NASDAQ:LULU) stands at 18.4, 23.4 and 19.7 respectively

The trailing twelve month Revenue of lululemon athletica inc. (NASDAQ:LULU) is reported at 2.92 Billion with income of 408.9 Million. The outstanding shares of lululemon athletica inc. (NASDAQ:LULU) are 129.29 Million. The institutional Ownership of the shares of 88.3 stands at 0.80%, this figure is decreased -1.43 in the last six months. The insider ownership for the shares of lululemon athletica inc. (NASDAQ:LULU) is ticked at 0.3%, the figure is plummeted -98.72% in the last six months.

Some other important financial aspects to be discussed here for lululemon athletica inc. (NASDAQ:LULU) is the Mean Target Price estimated by the analysts which stands at 163.14. The 52 week high of lululemon athletica inc. (NASDAQ:LULU) is placed at 164.79 and 52 week low is standing at 65.30.

Performance wise the shares of lululemon athletica inc. (NASDAQ:LULU) rose up 8.84% for the week, it also fell -5.91% for the monthly performance, while for the quarter it went up -12.52%. The shares increase 7.59% for the half year and flew up for the Year-To-Date performance. The shares of lululemon athletica inc. (NASDAQ:LULU) grew 98.78% for the yearly performance.